MEDTECHVISION 2024

Brooke Story – Former WW President, Becton Dickinson

Brooke will share the life-changing impact the medical device industry has had on her personally and her vision for ensuring life-saving medical device innovations reach as many people as possible.

Moderator: 

Adeyinka Pierce-Watkins – Director, Biodefense & Government Contracts, BDO USA

Panelists:

Dr. Anita Krishnan – Professor of Pediatrics, Children’s National Hospital

Jyoti Gupta – President & CEO, Women’s Health & X-ray, GE HealthCare

Jamie White – Founder & CEO,  innovative Health Science (iHS) Strategies, LLC

Jennifer Kuskowski – Head of Government Relations & Policy in the Americas, Siemens Healthineers

The last several years have seen the launch of multiple new and expanded public-private partnerships to build vital medical technology infrastructure. The number of local, state, and federal agencies committed to this goal continues to grow, but critical questions remain on how best to form and run these modern initiatives. Ensuring a pipeline of safe, effective and affordable medical devices for millions of people is not simple. It requires addressing problems as varied as identifying the best science and start-ups for funding, recruiting and training evolving workforces, and managing environmental and political uncertainty in critical global resources. Panelists from both sides of the public-private divide will discuss best practices and lessons learned for companies to be part of these emerging opportunities.

Moderator: 

Katrina Holland – Executive Director, MedTech Color

Panelists:

Heather Walsh – Head of New Business Opportunities of the Rx+ Business Accelerator, Astellas

Lisa Suennen – Managing Partner, AHA Ventures

Ranjini Srikantiah – Director, Strategic Initiatives, BD

Virginia Giddings – Vice President Exploration, Edwards Lifesciences

Healthcare Technology and medical science is evolving at breakneck speed. Unfortunately, many of the nimble startups leading the charge are finding themselves running short on capital and other resources long before they reach the market. The financial insecurity of the last several years has reduced investors’ tolerance for risk, pulling badly needed funds out of venture capital. Meanwhile, Medtech strategics are playing their own version of risk mitigation, holding off on acquisitions until the technology proves itself in a commercial product. This is leaving the average startup with far less while being asked to do much more. Large organizations, whether public or private, non-profit or academic, are now stepping in with a wide range of creative support services to help start-ups bridge the growing gap.

Michelle Tarver, MD, PhD – Acting Director, Center for Devices and Radiological Health (CDRH), Office of the Center Director

Moderator: 

Vernessa Pollard – Partner, DLA Piper

Moderator: 

Michelle Tarver, MD, PhD – Acting Director,  CDRH, Office of the Center Director

Panelists:

Julia Strandberg – Chief Business Leader, Connected Care & Monitoring, Philips

Kirsten Carroll – CEO, Kandu Health

Denise Graeber – SVP Clinical Services & Product Management, Signify Health

Mariel Fabro – Managing Partner, Beacon Launch Partners, LLC

Lisa Munn, RN – Regional Director of Operations, Sutter Care at Home

As care delivery increasingly moves out of the hospital setting, Medtech plays a pivotal role in empowering patients to receive quality care where it is most convenient for them. This panel explores the innovations transforming how care is delivered outside of traditional acute-care settings, how Medtechs need to innovate to support this shift, and what clinicians and patients really want. Specific themes to explore include the rise of the ambulatory surgery center and how Medtechs are enabling minimally invasive procedures in these settings, the revolutionizing of care at home that allow patients to prepare for operations and recover / manage their conditions at home, and more.